Table 5.

Values of the model parameter (beta), standard error (se), and p-values for the relationship between patient characteristics and TGA-IgA × ULN at follow-up visit, derived from univariable linear regression modeling and adjusted for disease duration.

	TGA-IgA × ULN at Follow-Up Visit
	Univariable		Adjusted for Disease Duration
	Beta (se)	p-Value	Beta (se)	p-Value
Country
Outside Italy vs. Italy	0.206 (0.328)	0.5313	0.093 (0.315)	0.7684
Sex
Female vs. male	0.325 (0.174)	0.0651	0.306 (0.166)	0.0685
Symptoms at diagnosis
Yes vs. No	−0.078 (0.278)	0.7810	0.058 (0.268)	0.8303
Cohabiting with CD
Yes vs. No	−0.118 (0.209)	0.5744	0.158 (0.19)	0.6607
Diagnosis by EGDS
Yes vs. No	−0.872 (0.154)	<0.0001	−0.756 (0.168)	<0.0001
Dietary consultation at diagnosis
Yes vs. No	0.306 (0.214)	0.1563	−0.007 (0.227)	0.9756
Dietary consultation at follow-up
Yes vs. No	−0.105 (0.177)	0.5559	0.092 (0.178)	0.6041
Symptoms after gluten ingestion
Yes vs. No	0.376 (0.277)	0.1822	0.364 (0.272)	0.1883
Age (years)	−0.066 (0.025)	0.0092	−0.908 (0.200)	<0.0001
Disease duration (yrs)	−0.077 (0.021)	0.0004
TGA-IgA × ULN at diagnosis	0.001 (0.000)	<0.0001	0.001 (0.000)	<0.0001
Relative difference TGA-IgA × ULN at diagnosis–follow-up visit	−0.002 (0.011)	0.8607	0.006 (0.620)	0.5380
Biagi score
Optimal vs. Suboptimal	0.227 (0.328)	0.4906	0.261 (0.313)	0.4055
Modified Leffler score
Optimal vs. Suboptimal	0.074 (0.219)	0.7354	0.094 (0.209)	0.6537